The increasing biopharmaceutical and biotechnology industries and the rising technological developments in single-cell analysis products are driving the demand for the market.
The global Single Cell Analysis Market is forecasted to reach USD 6.98 Billion by 2027, according to a new report by Reports and Data. The global Single-Cell Analysis market is forecasted to expand exponentially owing to the increasing biopharmaceutical and biotechnology industries. Furthermore, the market is also anticipated to be driven by the rising technological developments in single-cell analysis products in the forecasted timeline.
The rising prevalence of cancer globally is anticipated to propel the market growth to a certain extent in the forecasted timeline. One of the biggest causes of death globally is cancer. In the past couple of decades, the condition has undergone substantial growth and is projected to increase exponentially over the forecast timeframe. In 2018, approximately 1,735,350 new cancer cases were identified in the U. S., as per the National Institutes of Health (NIH), and 609,640 individuals died from the disease. Circulatory tumor cells are gaining growing therapeutic attention because they are essential to induce cancer development to be tracked and care modified. In these situations, single-cell sequencing has been used to pursue improved diagnostic and prognostic genetic markers.
The COVID-19 impact:
The distribution of Covid-19’s has influenced industrial activities worldwide. Over the weeks, the market has experienced a downturn that can continue in the coming months. The virus led to the implementation of lockdown, which disrupted the asset management program’s workings as the healthcare sector witnessed a collapse in several countries. They were loaded with patients infected by a coronavirus. Millions of people were infected, and thousands of them died, including the healthcare staff. Although the market suffered a significant setback at the time, the industry is bouncing back as there is a greater need for better management and upgrading the medical sector.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3716
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Single Cell Analysis market in these key regions.
Further key findings from the report suggest
The cancer segment is expected to dominate the market with a CAGR of 17.4% in the forecasted timeline. Single-cell research effectively addresses the data resolution problems, and a detailed description of tumor development, metastasis, immune evasion, and antibiotic resistance has been produced. These variables have contributed to the considerable adoption of this technology in molecular genetics, leading to this segment’s anticipated prominence.
The flow cytometry segment is anticipated to be gradually growing over the expected timeframe. The segment’s growth is due to the commonly used flow cytometry in the identification and calculation of cell or particle occupants’ physical and chemical characteristics.
The Asia Pacific is anticipated to experience the fastest growth in the Single Cell Analysis market, owing to growing biotechnology funding by suppliers and clients. The Single Cell Analysis market in the region is also spurred by increasing demand for biopharmaceuticals and rising R&D activities in the biopharmaceutical industry.
Key participants include General Electric Company, Fluidigm Corporation, NanoString Technologies, Inc., Fluxion Biosciences Inc, Luminex Corporation, Tecan Group Ltd., Promega Corporation, Becton, Dickinson and Company, Silicon Biosystems Menarini, Inc., Illumina, Inc., among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3716
For the purpose of this report, Reports and Data has segmented into the Global Single Cell Analysis Market on the basis of product, type, application, end-user, and region:
Product Outlook (Revenue, USD Billion; 2017-2027)
Automated Cell Counters
Type Outlook (Revenue, USD Billion; 2017-2027)
Technique Outlook (Revenue, USD Billion; 2017-2027)
Polymerase Chain Reaction
Application Outlook (Revenue, USD Billion; 2017-2027)
Non-invasive prenatal diagnosis
End-User Outlook (Revenue, USD Billion; 2017-2027)
Hospitals & Diagnostic Laboratories
Biotechnology & Pharmaceutical Companies
Academic & Research Laboratories
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3716
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.
Read More Reports:-
Fibrinogen Concentrate Market @ https://www.biospace.com/article/fibrinogen-concentrate-market-size-to-reach-usd-4-19-billion-in-2028-says-reports-and-data-/
Creatinine Measurement Market @ https://www.biospace.com/article/creatinine-measurement-market-size-to-value-at-usd-841-01-million-in-2028/
Point of Care Glucose Testing Market @ https://www.biospace.com/article/point-of-care-glucose-testing-market-size-to-reach-usd-8-17-billion-in-2028-says-reports-and-data-/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]